NBW Capital’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.79M | Buy |
53,896
+1,696
| +3% | +$172K | 1.25% | 29 |
|
|
2025
Q1 | $5.27M | Sell |
52,200
-48,658
| -48% | -$4.9M | 1.17% | 35 |
|
|
2024
Q4 | $9.01M | Sell |
100,858
-2,294
| -2% | -$202K | 1.67% | 18 |
|
|
2024
Q3 | $8.64M | Buy |
103,152
+819
| +0.8% | +$64.6K | 1.63% | 22 |
|
|
2024
Q2 | $7.88M | Sell |
102,333
-357
| -0.3% | -$26.1K | 1.55% | 19 |
|
|
2024
Q1 | $7.03M | Sell |
102,690
-1,449
| -1% | -$93.2K | 1.44% | 28 |
|
|
2023
Q4 | $6.02M | Sell |
104,139
-774
| -0.7% | -$41.3K | 1.32% | 29 |
|
|
2023
Q3 | $5.54M | Buy |
104,913
+1,746
| +2% | +$91.6K | 1.36% | 30 |
|
|
2023
Q2 | $5.58M | Sell |
103,167
-36,045
| -26% | -$1.88M | 1.3% | 32 |
|
|
2023
Q1 | $6.96M | Sell |
139,212
-2,011
| -1% | -$94.8K | 1.69% | 19 |
|
|
2022
Q4 | $6.53M | Buy |
141,223
+2,159
| +2% | +$93.5K | 1.67% | 18 |
|
|
2022
Q3 | $5.39M | Buy |
139,064
+5,279
| +4% | +$212K | 1.44% | 25 |
|
|
2022
Q2 | $4.99M | Sell |
133,785
-3,320
| -2% | -$135K | 1.37% | 29 |
|
|
2022
Q1 | $6.07M | Buy |
137,105
+3,138
| +2% | +$136K | 1.44% | 25 |
|
|
2021
Q4 | $5.69M | Buy |
133,967
+1,434
| +1% | +$60.3K | 1.27% | 36 |
|
|
2021
Q3 | $5.75M | Buy |
132,533
+1,612
| +1% | +$71.3K | 1.38% | 29 |
|
|
2021
Q2 | $5.6M | Buy |
130,921
+2,495
| +2% | +$105K | 1.36% | 29 |
|
|
2021
Q1 | $4.96M | Buy |
128,426
+21,802
| +20% | +$825K | 1.37% | 31 |
|
|
2020
Q4 | $3.83M | Sell |
106,624
-7,347
| -6% | -$265K | 1.16% | 38 |
|
|
2020
Q3 | $4.36M | Buy |
113,971
+2,667
| +2% | +$103K | 1.45% | 28 |
|
|
2020
Q2 | $3.91M | Buy |
111,304
+4,052
| +4% | +$146K | 1.4% | 30 |
|
|
2020
Q1 | $3.5M | Sell |
107,252
-4,254
| -4% | -$166K | 1.67% | 24 |
|
|
2019
Q4 | $5.04M | Sell |
111,506
-2,024
| -2% | -$84.7K | 1.43% | 25 |
|
|
2019
Q3 | $4.62M | Sell |
113,530
-5,690
| -5% | -$241K | 1.37% | 29 |
|
|
2019
Q2 | $5.12M | Sell |
119,220
-1,262
| -1% | -$48.5K | 1.41% | 33 |
|
|
2019
Q1 | $4.62M | Sell |
120,482
-2,208
| -2% | -$84.3K | 1.27% | 34 |
|
|
2018
Q4 | $4.34M | Sell |
122,690
-216
| -0.2% | -$7.83K | 1.54% | 26 |
|
|
2018
Q3 | $4.73M | Sell |
122,906
-1,107
| -0.9% | -$38.7K | 1.27% | 34 |
|
|
2018
Q2 | $4.05M | Buy |
124,013
+2,387
| +2% | +$72K | 1.16% | 36 |
|
|
2018
Q1 | $3.32M | Sell |
121,626
-13,196
| -10% | -$359K | 1.04% | 42 |
|
|
2017
Q4 | $3.34M | Sell |
134,822
-247
| -0.2% | -$6.81K | 0.88% | 52 |
|
|
2017
Q3 | $3.94M | Sell |
135,069
-402
| -0.3% | -$11.1K | 1.07% | 40 |
|
|
2017
Q2 | $3.75M | Buy |
+135,471
| New | +$3.6M | 1.04% | 40 |
|
Other funds holding BSX
NBW Capital's BSX Position: Q2 2025 in Review
NBW Capital increased its Boston Scientific (BSX) stake by 3.2% in Q2 2025, buying an estimated $172K and bringing the position to 53,896 shares worth $5.79M. The position accounts for 1.25% of the portfolio, ranked #29.
NBW Capital first reported a position in BSX in Q2 2017 and has held it in 33 quarters since. The position peaked at $9.01M in Q4 2024. 1,688 funds tracked by Wall St. Rank hold BSX as of Q2 2025.
- NBW Capital held 53,896 shares of Boston Scientific worth $5.79M as of Q2 2025.
- NBW Capital bought 1,696 Boston Scientific shares in Q2 2025, an estimated $172K.
- Boston Scientific made up 1.25% of NBW Capital's portfolio in Q2 2025, its #29 holding.
- NBW Capital first reported a position in Boston Scientific in Q2 2017 and has held it in 33 quarters since.
- NBW Capital's Boston Scientific position peaked at $9.01M in Q4 2024.
- 1,688 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.
Based on NBW Capital's 13F filing for Q2 2025, filed 13 Aug 2025.